G. Ferrara (Terni, Italy), I. Husar (Bucharest , Romania)
Factors affecting sputum conversion time in patients with smear positive tuberculosis
N. Durmus, M. Solakoglu Ucar, F. Ozturk, D. Polat, E. Torun (Istanbul, Bingol, Turkey)
|   |
Anti-tuberculosis drug resistance in Sivas, Turkey
U. Gonlugur, M. Bakici, T. Gonlugur, M. Hasbek (Sivas, Turkey)
| |
Antituberculosis drug resistance in a secondary care hospital in Turkey
T. Gonlugur, U. Gonlugur, M. Hasbek (Sivas, Turkey)
| |
A prospective study of prevalence of adverse drug reactions to the short course anti-tuberculosis regimen in Korea
S. H. Kim, B. H. Lee, K. D. Lee, Y. S. Kim, Y. K. Jee, J. S. Park, S. H. Kim (Seoul, Cheonan, Republic Of Korea)
| |
Does the radiological manifestation of drug resistant pulmonary tuberculosis (PTB) in HIV non-infected/infected patients differ – an Indian picture
G. Srivastava, S. Agarwal, S. Anupurva (Varanasi, U.P., India)
| |
BCG-itis – rare side effect of vaccination
L. S. Zdzislawa, B. Beata, M. Maciej, P. Elzbieta, B. Joachim (Rabka, Warsaw, Poland)
| |
Analysis of the deaths among tuberculosis patients in Iasi area throughout seven years (from 1998 to 2005)
L. Sirbu, C. Horodniceanu, V. Cojocariu, I. Rugina (Iasi, Romania)
| |
Do medical and dental students know enough about tuberculosis?
L. Nagorni Obradovic, J. Stojsic, M. Jojic (Belgrade, Serbia And Montenegro)
| |
Almost half the patients treated for pulmonary tuberculosis (TB) show evidence of obstructive airways disease (OAD)
B. Brashier, S. Gangavane, S. Valsa, S. N. Gaikwad, S. V. Ghorpade, S. Mandrekar, S. Salvi (Pune, Maharashtra, India)
| |
Outcomes of directly observed therapy at the Izmir Esrefpasa Tuberculosis Dispensary between 2003-2006
S. Alptekin, M. Aydin, S. Arslangiray, I. Coskunol, O. Ceyhan (Izmir, Turkey)
| |
Chylothorax secondary to tuberculous lymphadenitis in the setting of interstitial lung disease: a case report
B. Z. Balta, E. Sengul, S. Erturan, G. Aydin, K. Kaynak (Istanbul, Turkey)
| |
A normal erythrocyte sedimentation rate is a useful adjunct to exclude active tuberculosis
M. Murray, A. Hill (Scotland, United Kingdom)
| |
Tuberculosis-related deaths before and after the implementation of DOTS control program
M. Radovic, L. Ristic, S. Golubovic, M. Rancic, T. Pejcic, I. Stankovic, I. Djordjevic, Z. Stamenkovic, G. Pejovic (Nis, Serbia And Montenegro)
| |
The analysis of negative sputum TB relapses in Iasi County in the period 1998-2005
M. Panescu, C. Vasilescu, D. Mardare (Iasi, Romania)
| |
Drug resistant TB treatment outcomes in Novokuznetsk
A. L. Khanin, I. B. Viktorova, S. A. Dolgikh, V. M. Nikulshina, L. A. Malyk, A. I. Gordon (Novokuznetsk, Russian Federation)
| |
Resistance to second-line antituberculous drugs of Mtb strains in TB institute clinic
A. Zalutskaya, E. Sahalchyk, A. Nikolenko, L. Surkova (Minsk, Belarus)
| |
A review of sputum examination in a TB laboratory in Nigeria
A. Kehinde, F. Obaseki, O. Ishola (Ibadan, Nigeria)
| |
Mycobacterium kansasii is the main cause of respiratory infections associated with nontuberculous mycobacvteria (NTM) in patients from Department of Pneumonology of Warsaw Medical University
M. Nowacka-Mazurek, H. Grubek-Jaworska, A. Safianowska, R. Walkiewicz, R. Chazan (Warsaw, Poland)
| |
Lipid profile in tuberculous patients: a preliminary report
M. Metwally, H. Abdel Raheem (Assiut, Egypt)
| |
Isoniazid-induced pneumonitis – a rare entity
B. Seabra, A. Calvário, A. Carvalho, R. Duarte (V.N. Gaia, Portugal)
| |